PTAB Denies Hedge Fund's Bid For Painkiller Patent Reviews
The Patent Trial and Appeal Board on Thursday refused to review three Insys Pharma Inc. patents for the pain medication Subsys, ruling hedge fund manager Kyle Bass and his group failed...To view the full article, register now.
Already a subscriber? Click here to view full article